Medicure Inc’s (TSXV:MPH) most recent return on equity was a substandard 14.25% relative to its industry performance of 15.24% over the past year. MPH’s results could indicate a relatively inefficient ...

Medicure (CVE:MPH) has had a great run on the share market with its stock up by a significant 33% over the last three months. As most would know, fundamentals are what usually guide market price ...

I am writing today to help inform people who are new to the stock market and want to begin learning the link between company’s fundamentals and stock market performance. Medicure Inc (CVE:MPH) ...

WINNIPEG, MB, June 15, 2020 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is pleased to announce that on ...

WINNIPEG, MB, Aug. 20, 2020 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, today announced the termination of the marketing and ...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. One great example is ...

WINNIPEG, Manitoba - (November 2, 2009) Medicure Inc. ("Medicure" or the "Company") (TSX:MPH) today announces the appointment of Mr. Eric Johnstone, CA as Chief Financial Officer of the Company ...

Capital Group divested a 1.8% stake in medtech firm Poly Medicure for Rs 302 crore through open market transactions, ...

WINNIPEG, Medicure Inc., a cardiovascular pharmaceutical company, is pleased to announce that the United States Food and Drug Administration ("FDA") has approved its Abbreviated New Drug Application ( ...

Medicure's initial ownership interest and option rights were obtained for its lead role in structuring and participating in a majority interest purchase and financing of Apicore that occurred on July ...

WINNIPEG, MANITOBA--(Marketwired - Aug 13, 2014) - Medicure Inc. ("Medicure" or the "Company") (TSX VENTURE:MPH)(MCUJF), a specialty pharmaceutical company, announces that the preliminary results of ...

WINNIPEG, Medicure Inc., a specialty pharmaceutical company, is pleased to announce that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to ...